LifeMD, Inc. (LFMD)
NASDAQ: LFMD · Real-Time Price · USD
6.66
+0.03 (0.45%)
Oct 8, 2025, 9:54 AM EDT - Market open
LifeMD Market Cap
LifeMD has a market cap or net worth of $315.80 million as of October 8, 2025. Its market cap has increased by 49.31% in one year.
Market Cap
315.80M
Enterprise Value
300.20M
1-Year Change
49.31%
Ranking
Category
Stock Price
$6.66
Market Cap Chart
Since April 1, 2013, LifeMD's market cap has increased from $3.50M to $315.80M, an increase of 8,922.85%. That is a compound annual growth rate of 43.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 314.40M | 46.64% |
| Dec 31, 2024 | 214.40M | -31.89% |
| Dec 29, 2023 | 314.80M | 416.07% |
| Dec 30, 2022 | 61.00M | -48.48% |
| Dec 31, 2021 | 118.40M | -22.11% |
| Dec 31, 2020 | 152.00M | 2,391.80% |
| Dec 31, 2019 | 6.10M | -4.69% |
| Dec 31, 2018 | 6.40M | -57.62% |
| Dec 29, 2017 | 15.10M | 65.93% |
| Dec 30, 2016 | 9.10M | 145.95% |
| Dec 31, 2015 | 3.70M | 19.35% |
| Dec 31, 2014 | 3.10M | -59.21% |
| Dec 31, 2013 | 7.60M | 117.14% |
| Apr 1, 2013 | 3.50M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 758.63B |
| Johnson & Johnson | 453.15B |
| AbbVie | 406.64B |
| UnitedHealth Group | 324.93B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 265.89B |
| Novartis AG | 257.47B |
| Abbott Laboratories | 232.77B |